Ajaykumar Vishwakarma, MS, BDS, MBA
Founder and CEO of Cell Bioengines LLC
Biography
Mentor: Ali Salem, PhD
Comprehensive Exam:
Role of CD177 in Tumor-Infiltrating Regulatory T cells
Founded Cell Bioengines, LLC
Selected Publications
- Vishwakarma, A. and J. Karp (2017). Biology and Engineering of Stem Cell Niches, Elsevier.
- Vishwakaram, A, P. Sharpe, S. Shi, and M. Ramalingam. Stem Cell Biology and Tissue Engineering in Dental Sciences, Elsevier.
- Sabree SA, Voigt AP, Blackwell SE, Vishwakarma A, Chimenti MS, et al.Direct and indirect immune effects of CMP-001, a virus-like particle containing a TLR9 agonist. J Immunother Cancer. 2021 Jun;9(6):e002484.
- Kim MC, Borcherding N, Ahmed KK, Voigt AP, Vishwakarma A, et al.CD177 modulates the function and homeostasis of tumor-infiltrating regulatory T cells. Nat Commun. 2021 Oct 1;12(1):5764.
